The Food and Drug Administration (FDA) through the Center for Device Regulation, Radiation Health and Research (CDRRHR) has finalized the draft Administrative Order entitled “Rules and Regulations Governing the Issuance of an Authorization for an In Vitro Diagnostic Medical Device (IVD)”
In the interest of service and to seek the comments of the stakeholders that will be affected by the above-mentioned proposed policy, the FDA is inviting representatives from the IVD industry to attend the Virtual Public Hearing on 2 September 2022 at 2:00 P.M. via Google Meet. Eighty (80) slots have been allotted for those interested to attend the said activity. One (1) representative per company shall be accommodated.
To register and confirm your attendance, kindly accomplish the registration form through this link: https://docs.google.com/forms/d/1awCvG0egUocgEfuq6QAMa6CHpIFmLUHfIe8zkNbkJG4/edit?usp=sharing